The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen GmbH’s IntelliVue Patient...
READ MORELatest Posts -
Industry Insights
New Research Highlights Blood Clot Dangers of COVID-19
by OR Today Magazine | Apr 23, 2020
A special report published today in the journal Radiology outlines prevention, diagnosis and treatment of complications stemming from blood clots in patients with COVID-19. The journal also published two research letters and a case study on this topic. Clinicians...
READ MOREIntellego Technologies’ color-changing indicators aid in N95 mask decontamination
by OR Today Magazine | Apr 23, 2020
In the global fight against COVID-19, health care facilities and providers around the world are faced with critical shortages of disposable filtering facepiece respirators (FFRs), often referred to as N95 masks. Fortunately, innovative manufacturers are utilizing...
READ MOREAAAHC Shares Alignment of Standards with New Industry Recommendations for Infection Prevention When Performing Necessary Surgeries
by OR Today Magazine | Apr 23, 2020
In conjunction with the Ambulatory Surgery Center Association (ASCA), the Accreditation Association for Ambulatory Health Care (AAAHC) is encouraging its accredited ambulatory surgery centers (ASC) to follow new guidance intended to further protect patients, families,...
READ MOREExpert U.S. panel develops NIH treatment guidelines for COVID-19
by OR Today Magazine | Apr 21, 2020
Living document’ expected to be updated often as new clinical data accrue. A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19). These guidelines, intended for healthcare...
READ MOREThe Path Forward: Coronavirus Treatment Acceleration Program
by OR Today Magazine | Apr 21, 2020
By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs, Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research and Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research The coronavirus (COVID-19) pandemic is an...
READ MORE